Testing effectiveness (Phase 2)UnknownNCT02029378
What this trial is testing
Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Who this might be right for
Gullian Barre Syndrome
NHS Greater Glasgow and Clyde 30
Showing 4 of 4 results